Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms 2021-05-18 18:00
Nanoform's final clinical results confirm value proposition to the pharma industry 2021-05-18 13:48
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer 2021-05-18 12:14
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern 2021-05-18 11:50
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients 2021-05-18 08:15
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines 2021-05-17 20:54
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors 2021-05-17 20:00
Everest Medicines Announces China NMPA Has Accepted Biologics License Application for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer 2021-05-17 16:51
Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China 2021-05-17 15:00
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting 2021-05-17 09:00
Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial 2021-05-17 08:00
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021 2021-05-14 11:58
Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations 2021-05-14 10:33
Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China 2021-05-14 08:40
I-Mab Added to MSCI China Index 2021-05-13 20:00
An oral antiviral drug from Korea may be a problem solver for COVID-19 2021-05-13 16:37
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities 2021-05-13 13:00
Ascentage Pharma (6855.HK) Becomes a Constituent of MSCI China Small Cap Index 2021-05-13 08:28
Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19 2021-05-13 00:48
Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing 2021-05-12 18:12
1 244 245 246 247 248 412